Vascular complications of sickle cell disease

Ashar Usmani, Roberto Machado

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Sickle cell disease (SCD) is a monogenetic disorder caused by a mutation in the β-globin gene HBB leading to polymerization of red blood cells causing damage to cell membranes, increasing its rigidity and intravascular hemolysis. Multiple lines of evidence suggest that SCD can be viewed as pan-vasculopathy associated with multiple mechanisms but driven by hemoglobin S polymerization. Here we review the pathophysiology, clinical manifestations and management strategies for cerebrovascular disease, pulmonary hypertension and renal disease associated with SCD. These "vascular phenotypes" reflect the systemic nature of the complications of SCD and are a major threat to the well-being of patients with the disorder.

Original languageEnglish (US)
Pages (from-to)205-221
Number of pages17
JournalClinical Hemorheology and Microcirculation
Volume68
Issue number2-3
DOIs
StatePublished - Jan 1 2018

Fingerprint

Sickle Cell Anemia
Blood Vessels
Polymerization
Sickle Hemoglobin
Cerebrovascular Disorders
Globins
Hemolysis
Pulmonary Hypertension
Erythrocytes
Cell Membrane
Phenotype
Kidney
Mutation
Genes

Keywords

  • cerebral vasculopathy
  • nitric oxide
  • pulmonary hypertension
  • renal disease
  • Sickle cell disease

ASJC Scopus subject areas

  • Physiology
  • Hematology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Vascular complications of sickle cell disease. / Usmani, Ashar; Machado, Roberto.

In: Clinical Hemorheology and Microcirculation, Vol. 68, No. 2-3, 01.01.2018, p. 205-221.

Research output: Contribution to journalArticle

@article{4ad07d2bdefa424ab8b520629ec7fb44,
title = "Vascular complications of sickle cell disease",
abstract = "Sickle cell disease (SCD) is a monogenetic disorder caused by a mutation in the β-globin gene HBB leading to polymerization of red blood cells causing damage to cell membranes, increasing its rigidity and intravascular hemolysis. Multiple lines of evidence suggest that SCD can be viewed as pan-vasculopathy associated with multiple mechanisms but driven by hemoglobin S polymerization. Here we review the pathophysiology, clinical manifestations and management strategies for cerebrovascular disease, pulmonary hypertension and renal disease associated with SCD. These {"}vascular phenotypes{"} reflect the systemic nature of the complications of SCD and are a major threat to the well-being of patients with the disorder.",
keywords = "cerebral vasculopathy, nitric oxide, pulmonary hypertension, renal disease, Sickle cell disease",
author = "Ashar Usmani and Roberto Machado",
year = "2018",
month = "1",
day = "1",
doi = "10.3233/CH-189008",
language = "English (US)",
volume = "68",
pages = "205--221",
journal = "Clinical Hemorheology and Microcirculation",
issn = "1386-0291",
publisher = "IOS Press",
number = "2-3",

}

TY - JOUR

T1 - Vascular complications of sickle cell disease

AU - Usmani, Ashar

AU - Machado, Roberto

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Sickle cell disease (SCD) is a monogenetic disorder caused by a mutation in the β-globin gene HBB leading to polymerization of red blood cells causing damage to cell membranes, increasing its rigidity and intravascular hemolysis. Multiple lines of evidence suggest that SCD can be viewed as pan-vasculopathy associated with multiple mechanisms but driven by hemoglobin S polymerization. Here we review the pathophysiology, clinical manifestations and management strategies for cerebrovascular disease, pulmonary hypertension and renal disease associated with SCD. These "vascular phenotypes" reflect the systemic nature of the complications of SCD and are a major threat to the well-being of patients with the disorder.

AB - Sickle cell disease (SCD) is a monogenetic disorder caused by a mutation in the β-globin gene HBB leading to polymerization of red blood cells causing damage to cell membranes, increasing its rigidity and intravascular hemolysis. Multiple lines of evidence suggest that SCD can be viewed as pan-vasculopathy associated with multiple mechanisms but driven by hemoglobin S polymerization. Here we review the pathophysiology, clinical manifestations and management strategies for cerebrovascular disease, pulmonary hypertension and renal disease associated with SCD. These "vascular phenotypes" reflect the systemic nature of the complications of SCD and are a major threat to the well-being of patients with the disorder.

KW - cerebral vasculopathy

KW - nitric oxide

KW - pulmonary hypertension

KW - renal disease

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=85047777885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047777885&partnerID=8YFLogxK

U2 - 10.3233/CH-189008

DO - 10.3233/CH-189008

M3 - Article

VL - 68

SP - 205

EP - 221

JO - Clinical Hemorheology and Microcirculation

JF - Clinical Hemorheology and Microcirculation

SN - 1386-0291

IS - 2-3

ER -